Production (Stage)
Rani Therapeutics Holdings, Inc.
RANI
$0.5289
-$0.031-5.54%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 18.81% | -31.90% | 0.32% | 9.06% | -5.42% |
| Total Depreciation and Amortization | -5.64% | 2.70% | 1.57% | 2.82% | 9.25% |
| Total Amortization of Deferred Charges | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Non-Cash Items | -211.09% | 185.40% | 50.80% | 22.73% | -26.65% |
| Change in Net Operating Assets | 102.47% | -72.56% | -909.88% | -93.04% | 138.90% |
| Cash from Operations | 5.85% | -2.91% | 6.86% | 3.97% | 24.65% |
| Capital Expenditure | -64.52% | 75.20% | -32.98% | -422.22% | 89.22% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 616.30% | 329.63% | -91.03% | -35.81% | -23.28% |
| Cash from Investing | 623.09% | 437.53% | -92.81% | -36.61% | -22.45% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.00% | -200.00% | -- | -- | -- |
| Issuance of Common Stock | -99.55% | 4.57% | 5,335.15% | 36.36% | 26.04% |
| Repurchase of Common Stock | -155.56% | 35.71% | 41.67% | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -166.40% | -27.06% | 5,363.83% | 16.53% | 26.04% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1,332.82% | -117.30% | 89.97% | -333.27% | 13.57% |